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Abstract 
Because of the central role of dendritic cells and/or Langerhans cells (DC/LC) in the induction of cellular 
immune responses, pharmacological agents that modulate the recruitment of these cells might have a clinical 
interest. The present study was designed to evaluate the capacity of several pharmaceutical formulations to 
topically deliver granulocyte-macrophage colony-stimulating factor (GM-CSF) on human papillomavirus 
(HPV)-associated genital (pre)neoplastic lesions. The formulations were evaluated for their bioactivity and for 
their potential to recruit DC in organotypic cultures of HPV-transformed keratinocytes. We found that a 
bioadhesive polycarbophil gel (Noveon) at pH 5.5 is able to maintain the bioactivity of GM-CSF at 4 or 37°C for 
at least 7 days, whereas a decreased activity of GM-CSF was observed when the molecule is included in other 
polymer gels. GM-CSF incorporated in the polycarbophil gel was also a potent factor in enhancing the 
colonization of DC into organotypic cultures of HPV-transformed keratinocytes since the infiltration of DC in 
the in vitro-formed (pre)neoplastic epithelium was very low under basal conditions and dramatically increased in 
the presence of GM-CSF gel. We next demonstrated that GM-CSF incorporated in polycarbophil gel induces the 
recruitment of human DC in a human (pre)neoplastic epithelium grafted into NOD/SCID mice. The efficacy of 
GM-CSF in this formulation was equivalent to that observed with liquid GM-CSF. These results suggest that 
GM-CSF incorporated in polycarbophil gel could play an important role in the recruitment of DC/LC in mucosal 
surfaces and be useful as a new immunotherapeutic approach for genital HPV-associated (pre)neoplastic lesions. 
 
Morbidity and mortality caused by human papillomavirus (HPV) infection is a major health problem in 
developing countries and in the industrialized world, where direct and indirect costs from disease are very high. 
HPVs are common sexually transmitted pathogens inducing a spectrum of diseases ranging from benign genital 
warts to invasive carcinoma. Some types of HPV have been shown to be directly involved in the malignant 
transformation process, especially in the uterine cervix. Up to 99% of cases of cervical cancer and its precursors 
(squamous intraepithelial lesions [SILs]) may be attributed to infection by oncogenic HPV (3). However, HPV 
alone is not sufficient for tumor progression (17). The role of intrinsic immunity in controlling HPV infection 
and the subsequent development of SILs is shown indirectly by the increased frequency of HPV-associated 
lesions in patients with depressed cell-mediated immunity (11, 34). Although viral antigens are expressed in the 
majority of (pre)neoplastic lesions, progression to invasive cancer may occur, suggesting the existence of some 
qualitative and/or quantitative perturbations in the antigenic presentation function. This hypothesis is reinforced 
by the observation that most genital warts and SILs are characterized by a decreased density and function of 
Langerhans cells (LC) compared to the normal paired squamous epithelium (16, 29, 30). Since the immune 
system clearly plays an important role in influencing the natural history of the disease, there is some evidence 
that immune response modifiers may have therapeutic value for these lesions. There is now accumulating 
evidence that epithelial cells may influence immune reactions in squamous mucosa through the production of 
cytokines and/or chemokines. Indeed, keratinocytes are capable of producing a large array of cytokines, such as 
granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-1α (IL-1α), tumor necrosis factor 
alpha, chemokines (e.g., macrophage inflammatory protein 3α [MIP3α]/CCL20, monocyte chemoattractant 
protein 1[MCP-1], and RANTES), and β-defensins, all of which can importantly influence the migration, 
activation and/or differentiation potential of LC and/or dendritic cells (LC/DC) (5, 9, 22, 31, 44). Interestingly, 
SILs have been associated with an intermittent pattern of staining for MIP3α compared with normal exocervix 
(16). Moreover, an inverse correlation between the expression of the MCP-1 gene and the HPV oncogenes E6 
and E7 in cervical carcinoma cell lines has been described (38). The production profile of these cytokines and/or 
chemokines is most likely influenced by the complex differentiation state of the keratinocytes and thus has the 
potential to be altered after tumorigenesis (41). One of the most potent cytokines/chemokines used to modify the 
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immunogenicity of tumors appears to be GM-CSF (10). GM-CSF, produced by keratinocytes, acts as a selective 
chemoattractive molecule for the migration of DC into the epithelium and mediates the maturation of LC and DC 
(23, 32). Exposure of DC/LC to GM-CSF in vitro prolongs the survival of these cells and increases their capacity 
to present antigens to lymphocytes (26). Moreover, a correlation has been observed in vivo between the levels of 
GM-CSF produced by some carcinomas and the distribution and/or differentiation of tumor-associated DC (6). It 
has previously been demonstrated, by using the organotypic raft culture system, that GM-CSF is a potent factor 
in enhancing the colonization of DC/LC in a (pre)neoplastic epithelium formed in vitro (20). Moreover, the 
infiltration of organotypic cultures by DC specifically induced the apoptosis of keratinocytes transformed by 
HPV, whereas DC were not affected (18). These data suggest that the recruitment of DC into a virus-infected 
and/or (pre) neoplastic epithelium might be beneficial, not only by stimulating antiviral and antitumor immune 
responses but also by inducing the death of virus-infected and -transformed cells. Because of the central role of 
DC/LC in the induction and regulation of cellular immune responses, pharmacological agents that modulate the 
recruitment and function of these cells might be of clinical interest. 
The present study was designed to evaluate the capacity of several pharmaceutical formulations to topically 
deliver GM-CSF to HPV-associated lesions. 
One major problem associated with genital drug delivery is that the physiological conditions imposed by the 
protective mechanisms of the cervix or the vagina often lead to a limited contact time of administered drugs with 
the mucosa and a short duration of therapeutic efficacy, making a frequent dosing regimen necessary (39, 42). 
Patients are known to tolerate gels better than other conventional dosage forms such as inserts or ointments. 
Some bioadhesive polymers have attracted considerable attention for their opportunity to prolong the contact of 
drug with a mucosal surface without inducing adverse local effects on the epithelium (37). 
In this study, we investigated the properties of hydroxypropyl cellulose, polycarbophil, carbomer, and poloxamer 
polymers to deliver bioactive GM-CSF. Cellulose derivatives have been widely used as thickening agents in 
cervicovaginal formulations (15, 27, 28). Carbopols and polycarbophils are acrylic acid polymers, which have 
good bioadhesive properties and prolonged retention of formulation at the site of administration (25). Poloxamer, 
a block copolymer made of polyoxyethylene and polyoxypropylene, is also known for its excellent 
compatibility. It forms a gelling liquid in situ that has been recognized as a convenient dosage form for topical 
application. The liquid applied to mucosal area turns into a gel with temperature increases (4). 
After incorporation of GM-CSF into these hydrogels, the different formulations were evaluated for their 
bioactivity after storage at 4 or 37°C and for their potential to recruit DC in HPV-associated (pre)neoplastic 
epithelium formed in vitro (organotypic cultures of HPV-transformed keratinocytes) or maintained in vivo (in a 
NOD/SCID mice model). 
MATERIALS AND METHODS 
Preparation of the hydrogels.  
Poloxamer P407 (Lutrol) was supplied from BASF (Ludwigshafen, Germany). Carbomer (Carbopol 974P) and 
polycarbophil (Noveon AA1) were gifts from Noveon (Brussels, Belgium). Hydroxypropyl cellulose (Klucel 
GF) was obtained from Hercules (Düsseldorf, Germany). GM-CSF was received from Novartis (Brussels, 
Belgium). All other chemicals were of analytical grade. The carbopol gel (1.3% [wt/wt]) was prepared by 
dispersing the carbopol resin in purified water. The mixture was stirred until thickening occurred and then 
neutralized by dropwise addition of 40% (wt/wt) tromethamine until a transparent gel appeared. The quantity of 
tromethamine was adjusted to achieve a gel pH of 6.9. The polycarbophil gel (1.0% [wt/wt]) was prepared by 
dispersing Noveon AA1 in purified water. The mixture was stirred until thickening occurred and then neutralized 
by dropwise addition of 40% (wt/wt) tromethamine until a transparent gel appeared. The quantity of 
tromethamine was adjusted to achieve a gel pH of 6.9 or 5.5. The poloxamer gel was prepared by the cold 
method. Poloxamer P407 (20% [wt/wt]) was slowly added under gentle mixing to 0.05 M phosphate buffer (pH 
6.9) at a temperature of 4°C. The mixture was allowed to dissolve overnight at 4°C until a clear solution was 
obtained. Finally, 7% (wt/wt) hydroxypropyl cellulose was slowly added to 0.05 M phosphate buffer (pH 6.9) 
under gentle mixing until a transparent gel appeared. 
GM-CSF bioassay with TF-1 cells.  
A total of 900 pg of GM-CSF, diluted in RPMI 1640 medium with 2% fetal calf serum (FCS), was incorporated 
per gram of different gels by gentle mixing. The gels were kept for different periods of time at 37 or 4°C and 
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protected from light to avoid degradation. After 0, 1, 2, 3, and 7 days, the gels were diluted with 6 ml of RPMI 
1640-2% FCS. The final concentration of GM-CSF was 150 ng/ml. This concentration was chosen to be in the 
exponential growth curve of TF-1 cells (data not shown). After filtration on 0.45-µm-pore-sized filters (Millex-
HV; Millipore, Bedford, Mass.), solutions were stored at -20°C before the bioassay. GM-CSF in solution (150 
ng/ml) was also kept during the different intervals of time at 37 and 4°C and filtered before storage. 
The factor-dependent human cell line TF-1 (ATCC CRL-2003) was cultivated following previously published 
recommendations (24) with minor modifications. Briefly, the cells were incubated in RPMI 1640 medium 
containing 10% fetal bovine serum and GM-CSF (5 ng/ml) at 37°C and with 5% CO2. Cells were deprived of 
GM-CSF for 24 h and were cultured in the presence of 2% FCS. The cells were plated in a round-bottomed 96-
well microtiter plate at 50,000 cells per well, in 100 µl of RPMI 1640-2% FCS and 100 µl of GM-CSF 
previously included in the different polymers for various intervals of time. The tests were performed in 
quintuplicate. The cultures were incubated for 24 h in the presence of 3H-labeled thymidine (2 µCi/well, 7 
Ci/mmol; Moravek Biochemicals, Brea, Calif). Cells were harvested by an automated sample harvester 
(Canberra Packard, Tilburg, The Netherlands) and counted in a Top Count liquid scintillation counter (Canberra 
Packard). 
DC culture and labeling with lipophilic fluorescent cell tracer.  
DC were generated from the adherent fraction of human peripheral blood mononuclear cells (PBMCs) with 800 
U of GM-CSF (Novartis)/ml and 20 U of IL-4 (Bio-source Europe, Nivelles, Belgium)/ml, as previously 
described (19). DC generated for this study constituted a 90% pure cell population based on several criteria 
including morphology, forward- and side-scatter values observed by fluorescence-activated cell sorter analysis, 
and surface phenotype characteristics (CD1a+, HLA-DR+, major histocompatibility complex class I positive, 
CD4+, CD54+, CD86dim, CD3-, CD20-, and CD14-). 
The DC were labeled with a lipophilic fluorescent marker (CM-DiL; Molecular Probes, Leiden, The 
Netherlands) according to a previously described procedure with minor modifications. Briefly, 4 x 106 DC were 
resuspended in 1 ml of phosphate-buffered saline (PBS) and heated to 37°C. The CM-DiL marker was diluted in 
1 ml of PBS preheated to 37°C to obtain a final concentration of 16 µg/ml. The dye was mixed for several 
seconds until the dye was evenly distributed. This solution was immediately transferred to the cell suspension 
and rapidly mixed by pipetting. The cells were incubated for 2 min at 37°C and then for 2 min on ice. Finally, 
they were transferred in 40 ml of PBS at 4°C, centrifuged, and resuspended in the appropriate medium. 
Organotypic cultures.  
Organotypic cultures of HPV-transformed keratinocytes (SiHa cell line) (13) were prepared as previously 
reported (20). After a 2-week stratification of keratinocytes, labeled DC were seeded on top of the in vitro-
formed epithelium at a concentration of 2 x 105 cells/50 µl of culture medium. The organotypic culture was then 
placed on a polycarbophil gel containing either 800 U of GM-CSF/ml or no gel. The positive control was a 
solution of liquid GM-CSF at a concentration of 800 U/ml. After 48 h at 37°C, the collagen rafts were harvested. 
The cultures were then embedded in optimal cutting temperature compound (Tissue Tek; Sakura, Zouterwoude, 
The Netherlands) at -70°C and sectioned with a cryostat. The organotypic cultures were counterstained with the 
fluorescent dye 4',6-diamidine-2-phenylindole dihydro-chloride (DAPI; Roche Diagnostics, Brussels, Belgium). 
Infiltration of fluorescent DC was visualized with a Leica (Heidelberg, Germany) DMLB fluorescent microscope 
equipped with a 40X lens objective. 
Assessment of CD1a+ cell infiltration in organotypic cultures.  
The density of DC migration into the epithelial layer was assessed by the avidin-biotin-peroxidase technique 
(Vectastain ABC kit; Vector Laboratories, Burlingame, Calif.) with an anti-CD1a monoclonal antibody (clone 
NA1/34; Dako, Glostrup, Denmark). Nine-micrometer frozen sections were fixed in cold acetone for 3 min, and 
endogenous peroxidases were blocked with 0.1% H2O2 for 30 min. Sections were then incubated sequentially 
with anti-CDla antibody (at a 1/40 dilution in PBS-2% bovine serum albumin-0.01 M NaN3) or with an isotype-
matched control antibody for 1 h, a biotinylated mouse anti-immunoglobulin antibody for 30 min, and 
streptavidin-horseradish peroxidase AB complex for another 30 min. Positive cells were visualized by a 3,3'-
diarninobenzidine substrate. The sections were counterstained with hematoxylin. The DC infiltration in 
organotypic cultures was evaluated by measuring the surface of immunostained cells with a computerized system 
of image analysis (CAS; Becton-Dickinson, Erembodegem, Belgium) following a previously described method 
(7). The entire surface of each culture section was analyzed, and five sections of each culture were stained with 
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anti-CD1a. The positive surface was expressed as the percentage of the total surface analyzed. Statistical analysis 
was performed with the Student t test (Instat Mac 2.01 software; Graph-Pad Software, San Diego, Calif.). 
Xenograft assay with NOD/SCID mice.  
HPV-transformed keratinocytes (2 x 105) from the CasKi cell line (ATCC CRL-1550) were plated on collagen 
gel (2 mg of type I collagen isolated from rat tail tendons/ml) inserted in Teflon rings (Renner, Dannstadt, 
Germany) and maintained in culture for 1 day before transplantation onto mice. Twelve-week-old NOD/SCID 
mice were used for this study. They were housed under sterile conditions, and water and feed were provided at 
will. Before transplantation, the cells were washed and the medium was drained. The cell-coated collagen gels 
were then covered with a silicone transplantation chamber (Renner) and implanted entirely onto the dorsal 
muscle fascia of mice as previously described (2,14). The mice were killed 24 days later. The transplants were 
excised, embedded in optimal cutting temperature compound (Tissue Tek; Sakura), and frozen on dry ice for 
cryostat sectioning. In DC recruitment experiments, 2 x 106 fluorescence-labeled DC were intravenously injected 
at day 21. PBS or polycarbophil gel alone or with chemoattractants (GM-CSF liquid, 4 x 105 U/ml; or GM-CSF 
incorporated in polycarbophil gel, 4 x 105 U/g of gel) was injected twice (each injection, 200 µl) into the 
transplantation chamber 24 and 48 h before the mice were sacrificed. Transplant sections were counterstained 
with the fluorescent dye DAPI (Roche Diagnostics). Infiltration of fluorescent DC was visualized with a Leica 
DMLB fluorescent microscope equipped with a 40x objective. Fluorescent DC in the epithelium were counted 
and, after anti-keratin immunolabeling, the epithelial surface was evaluated with the CAS computerized system 
of image analysis (Becton-Dickinson). Infiltration results were expressed as the numbers of DC per square 
millimeter of epithelium. Statistical analysis was performed with the Student t test (Instat Mac 2.01 software; 
Graph-Pad). 
Immunofluorescent labeling.  
Graft cryosections (each, 5 µm in thickness) were fixed in acetone at -20°C and in 80% methanol at 4°C. They 
were then incubated for 60 min at room temperature with the primary antibodies anti-mouse type IV collagen 
(SIF105, rabbit anti-mouse; a gift of A. Noël) and anti-human keratin (KL1, mouse anti-human; Immunotech, 
Marseille, France). The appropriate secondary antibodies were then applied for 30 min: swine anti-rabbit 
conjugated to Texas red (Dako) and sheep anti-mouse conjugated to fluorescein-isothiocyanate (Sigma-Aldrich). 
For double immunofluorescence-la-beling studies, sections were first incubated with the two primary antibodies 
and then with fluorescein isothiocyanate- and Texas red-conjugated secondary antibodies. After being washed in 
PBS, coverslips were mounted, and labeling was analyzed under a microscope equipped with epifluorescence 
optics. 
RESULTS 
Analysis of GM-CSF bioactivity following incorporation into different polymers at 4 and 37°C by a 
bioassay with TF-1 cells. 
The biological activity of GM-CSF was measured at different time intervals after incorporation into the 
hydrogels by a bioassay with the GM-CSF-dependent TF-1 cell line. The injectable solution (Leucomax; 
Novartis) was chosen as a positive control. The four polymers were tested at a pH value of 6.9, which was 
reported to be optimal for GM-CSF stability and which corresponds to the pH value of the injectable solution 
(data from Novartis). As polycarbophil was found to be a particularly convenient polymer for cervicovaginal 
formulations; as it is usually recommended that cervicovaginal formulations be developed at acidic pH values, 
the polycarbophil hydrogel was also tested at pH 5.5. 
As shown in Fig. 1, there was a decrease in the bioactivity of the injectable solution of GM-CSF, more important 
at 37°C than at 4°C, which is in agreement with previous data (35). We also observed an important reduction in 
GM-CSF activity after incorporation in the hydroxypropyl cellulose (Klucel) or in the poloxamer hydrogel 
(Lutrol) at both temperatures. In contrast, polycarbophil gel (Noveon) at pH 5.5 induced protection against GM-
CSF degradation. However, this protective effect was not observed at pH 6.9. Carbomer (Carbopol) conserved 
an activity of GM-CSF similar to that observed with the injectable solution at both temperatures and during at 
least a week. However, a pH reduction to 5.5 induced a rapid decrease in the activity of GM-CSF incorporated 
into carbomer gel at 4 and 37°C (data not shown). 
These results suggest that the polycarbophil gel (Noveon) at pH 5.5 could be convenient for topical application 
of GM-CSF on a squamous cell genital mucosa. 
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Influence of GM-CSF incorporated in polycarbophil gel on the recruitment of DC in in vitro-formed 
(pre)neoplastic epithelium.  
We investigated whether GM-CSF included in a polymer modulates the ability of DC to infiltrate an in vitro-
formed (pre)neoplastic epithelium, reminiscent of high-grade (pre) neoplastic lesions observed in vivo. 
Monocytic precursors from the plastic adherent fraction of human PBMCs cultivated in the presence of 800 U of 
GM-CSF/ml and 20 U of IL-4/ml for 7 days showed a morphology of DC with abundant dendritic membrane 
protrusions (data not shown). By fluorescence-activated cell sorter analysis (Fig. 2), these cells also displayed 
phenotypical features typical of DC with the presence of CDla, CD4, CD86, and CD54 (intercellular adhesion 
molecule 1) antigens; a moderate expression of major histocompatibility complex class II (HLA-DR) molecules; 
and the absence of macrophage (CD14), B-cell (CD20), and T-cell (CD3) markers. DC were layered on top of 
organotypic cultures of HPV-transformed keratinocytes in the presence of GM-CSF incorporated or not into the 
polycarbophil gel. The effect of GM-CSF on DC infiltration was assessed by examining cryosections of 
organotypic cultures frozen 48 h after the addition of GM-CSF. The ability of the GM-CSF gel to modulate the 
infiltration of DC was determined by the evaluation of fluorescent DC into the organotypic cultures. DC layered 
onto organotypic cultures of SiHa poorly infiltrated the epithelial cell layers in the absence of GM-CSF, whereas 
GM-CSF in solution or incorporated in the gel caused a significant increase in the density of DC observed within 
the epithelial sheet. Quantitative analysis of DC infiltration was performed with organotypic cultures derived 
from the HPV-transformed cell line SiHa (Fig. 3). The density of DC in the in vitro-formed epithelium was 
quantified by evaluating the surface labeled with the anti-CDla antibody throughout the full thickness of 
organotypic cultures. Under basal conditions (in the absence of GM-CSF, either liquid or when gel incorporation 
had been carried out), the level of DC infiltration in the cultures was low (1.64 ± 0.78% of CD la-labeled 
surface). When the medium of organotypic cultures of HPV-positive cell lines was supplemented with GM-CSF, 
the infiltration of DC significantly improved (28.33 ± 8.11% of CD1a-labeled surface); the density of DC 
observed in these conditions was similar to that induced by the GM-CSF included in the gel (25.38 ± 5.81% of 
CDla-labeled surface). 
GM-CSF included in polycarbophil gel stimulates the migration of human DC in xenografts of HPV-
transformed keratinocytes.  
To address the in vivo efficacy of GM-CSF included in polycarbophil gel, HPV-transformed transplanted 
keratinocytes cultured on a collagen gel were grafted onto the backs of NOD/SCID mice. Twenty-four days after 
transplantation, the mice were killed and the grafts were removed for immunohistological analysis. Histological 
examination of thin sections revealed that the growth pattern of the grafts reproduced a high-grade squamous 
(pre)neoplastic lesion and that the collagen gel was replaced by granulation tissue (data not shown). 
Transplantation of HPV-positive keratinocytes induced an angiogenic response in the host tissue starting from 
vessels of the dorsal muscle and subsequently extending far up into the collagen gel. The vessels sprouted into 
the tumor epithelium, which started to invade the newly formed granulation tissue (data not shown). 
To demonstrate the efficacy of GM-CSF incorporated into polycarbophil gel, two groups of five mice each were 
treated by injecting 200 µl of GM-CSF, in PBS or in the gel, in the transplantation chamber covering the 
(pre)neoplastic epithelium, daily for 2 days prior to killing the mice. A control group of mice was treated with 
PBS alone. At the first application of GM-CSF, 2 x 106 human DC prelabeled with fluorescent tracer were 
intravenously injected into the mice. The grafts were harvested 1 day after the last administration of GM-CSF 
and processed for microscopic examination. The DC infiltration in transplants was assessed by looking for 
stained DC in histological sections. The application of GM-CSF in the transplantation chamber resulted in a 
significant (P < 0.001) recruitment of DC in the tumor grafts of treated animals, while DC were rarely detected 
in the epithelia of control mice. Quantitative analysis of DC infiltration was performed by determining the 
number of DC per square millimeter of epithelial tissue (Fig. 4). The rate of DC infiltration in the grafts was very 
low (1.1 ± 1.4 DC/mm2) in the absence of GM-CSF and drastically increased after treatment with liquid GM-
CSF (16.6 ± 14.6 DC/mm2). Similar results were observed when GM-CSF was incorporated into polycarbophil 
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FIG. 1: Proliferation response of TF-1 cell line after incubation with GM-CSF extracted at different time 
intervals from the hydrogels stored at 4 or 37°C. Growth was measured by 3H-labeled thymidine incorporation. 








Published in: Antimicrobial Agents and Chemotherapy (2004), vol.48, iss.11, pp. 4342-4348 
Status: Postprint (Author’s version) 
FIG. 2: Double staining and flow cytometry analysis of DC generated from cultures of adherent human PBMCs 
in the presence of GM-CSF and IL-4 during 7 days. Results are displayed as dot plots. Cells were labeled with 
CD1a-fluorescein isothiocyanate antibody versus indicated phycoerythrin-conjugated antibodies. Quadrant 
setting was performed according to the reactivities of isotype-matched controls. One representative experiment 
is shown out of more than 10 experiments performed. 
 
FIG. 3: Quantitative evaluation of DC infiltration into organotypic cultures of HPV-transformed keratinocytes 
under the influence of GM-CSF incorporated or not into polycarbophil gel. The penetration of DC was followed 
by immunolabeling with anti-CD1a. Results are expressed as the mean percentages of surface labeled with anti-
CD1a compared to unlabeled surface of the epithelial sheet ± the standard deviation (five experiments). 
Asterisks indicate statistically significant differences (***,P < 0.001). 
 
FIG. 4: Quantitative evaluation of DC infiltration into transplants of HPV-transformed keratinocytes. The 
results are expressed as numbers of DC per square millimeter of HPV-positive epithelium ± the standard 
deviation (five experiments were conducted for each condition). Asterisks indicate statistically significant 
differences (***, P < 0.001). 
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DISCUSSION 
Different mucoadhesive drug delivery systems based on hydrogels have been recently developed (12, 33, 40). 
Their ability to interact with mucus glycoproteins and to remain localized to a specific site might help to deliver 
molecules important for antiviral or antitumor immune responses. It has previously been shown that GM-CSF 
increases the ability of monocyte-derived DC to infiltrate a (pre)neoplastic epithelium formed in vitro, 
suggesting that the effect of a treatment based on the local administration of GM-CSF might be a recruitment 
into the dysplastic epithelium of LC (20). LC are the main professional antigen-presenting cells in squamous 
mucosa. These cells are able to capture viral or tumor antigens and, after migration in the draining lymph nodes, 
to present these antigens to T cells. Subsequently, the sensitized T lymphocytes could reach the squamous 
epithelium and kill the cells bearing the antigens at the origin of the sensitization. 
In this study, we analyzed the stability and bioactivity of GM-CSF in different formulations of hydrogels. As the 
quantitative and functional deficit of DC/LC is a constant immune alteration in genital HPV-associated lesions 
(43), we used epithelial sheets of HPV-transformed keratinocytes (7, 8, 20, 21, 36) maintained in vitro (on a 
collagen gel) or in vivo (in NOD/SCID mice). 
We first demonstrated that polycarbophil gel at pH 5.5 conserves the bioactivity of GM-CSF at 4 or 37°C for at 
least 7 days, whereas a decrease in the biological activity of GM-CSF was observed mainly after incorporation 
into hydroxypropyl cellulose or poloxamer hydrogels at both temperatures. This could be due to interactions 
with the polymers that are present in the formulations at a high concentration to achieve the suitable viscosity. 
The residual bioactivity of GM-CSF incorporated into both gels at pH 6.9 was surprisingly different. These data 
could be attributed to the carboxyl group present in the polycarbophil gel and absent in the hydroxypropyl 
cellulose and poloxamer formulations. Indeed, similar results were reported with carboxylic acid containing 
polymers and carbomers, which were shown to inhibit the degradation of insulin and other peptide drugs (1). 
GM-CSF bioactivity evaluated after storage in the polycarbophil hydrogel formulated at a pH value of 5.5 was 
better than that observed for GM-CSF in solution. Moreover, the fact that the pH must be decreased to observe 
the protective effect of the polymer is completely compatible with the physiological cervicovaginal pH. 
Since the bioassay with TF-1 cells required the dilution of the different hydrogels, the bioactivity detected was 
that of solutions of GM-CSF. It was, therefore, important to determine whether the gel affected the activity of 
GM-CSF or not. Indeed, due to their viscosity, the hydrogels could interfere with the diffusion and the 
bioavailability of GM-CSF. We have demonstrated that GM-CSF included in the polycarbophil gel at pH 5.5 
stimulated the infiltration of DC into an in vitro equivalent of HPV-associated (pre)neoplastic epithelium, 
suggesting that this hydrogel does not impair protein release in vitro. 
Besides the stabilization of GM-CSF with a gel formulation and its efficacy in vitro, this report also describes the 
potential interest of a mouse xenograft model for the in vivo testing of new immunopharmacological treatments. 
The use of the dorsal muscle of the mouse as a transplantation site and a transplantation chamber were shown to 
be useful to evaluate the effects of topical formulations. Moreover, the model reported here has the advantage of 
using transformed keratinocytes derived from cell lines, available in unlimited quantities and capable of 
generating reproducible data. By using this model, we have demonstrated that GM-CSF included in 
polycarbophil gel is able to stimulate the intraepithelial migration of human DC in vivo. It remains to determine 
whether this DC recruitment with GM-CSF will be effective at inducing efficient immune responses against viral 
or tumor antigens. 
Taken together, these results suggest that the polycarbophil gel (Noveon) is compatible with the diffusion of 
bioactive GM-CSF with the advantage of stabilizing the protein. Moreover, GM-CSF included in this gel 
formulation is also able to recruit DC into HPV-transformed (pre)neoplastic epithelial tissues in vitro and in 
vivo. This formulation, which is recommended for genital application, might restore some immune functions that 
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